NCT05621668 2025-10-20A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone SarcomaM.D. Anderson Cancer CenterPhase 1 Recruiting40 enrolled